Tg Therapeutics reported $456.22M in Cash and Equivalent for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Acceleron Pharma XLRN:US $ 336.2M 119.31M
Amgen AMGN:US $ 6630M 518M
Ardelyx ARDX:US $ 86.74M 2.68M
Arena Pharmaceuticals ARNA:US $ 514.18M 81.2M
Arrowhead Research ARWR:US $ 325.98M 46.4M
Bayer BAYN:GR € 3389M 2161M
Biogen BIIB:US $ 1742M 524.5M
Corcept Therapeutics CORT:US $ 95.43M 43.05M
Curis CRIS:US $ 75.03M 36.01M
Dynavax Technologies DVAX:US $ 129.61M 50.55M
Gilead Sciences GILD:US $ 7361M 3296M
Infinity Pharmaceuticals INFI:US $ 97.26M 9.5M
Intercept Pharmaceuticals ICPT:US $ 145.62M 52.67M
Karyopharm Therapeutics KPTI:US $ 141.31M 52.84M
Novartis NOVN:VX SF 5117M 1316M
Novavax NVAX:US $ 238.03M 4.68M
Ptc Therapeutics PTCT:US $ 177.35M 30.72M
Puma Biotechnology PBYI:US $ 89.85M 5.8M
Regeneron Pharmaceuticals REGN:US $ 2072.2M 634.3M
Spectrum Pharmaceuticals SPPI:US $ 114.57M 45.05M
Tg Therapeutics TGTX:US $ 456.22M 15.3M
Verastem VSTM:US $ 24.97M 10.54M
Vertex Pharmaceuticals VRTX:US $ 6063.68M 240.65M
Ziopharm Oncology ZIOP:US $ 76.75M 23.31M